SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors
Evangelos Terpos, Dimitris Stellas, Margherita Rosati, Theodoros Ν. Sergentanis, Xintao Hu, Marianna Politou, Vassiliki Pappa, Ioannis Ntanasis‐Stathopoulos, Sevasti Karaliota, Jenifer Bear, Duncan Donohue, Maria Pagoni, Elisavet Grouzi, Eleni Korompoki, George N. Pavlakis, Barbara K. Felber, Meletios Α. Dimopoulos
Topics & Concepts
MedicineAntibodyVirologyPersistence (discontinuity)Coronavirus disease 2019 (COVID-19)Convalescent plasmaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Neutralizing antibody2019-20 coronavirus outbreakSpike ProteinImmunologyInternal medicineOutbreakEngineeringDiseaseInfectious disease (medical specialty)Geotechnical engineeringSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing